Québec

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• COPD1 trial
• Hidradenitis suppurativa1 trial

Phase

• Phase 21 trial
• Phase 31 trial

Status

• Completed1 trial
• Recruiting1 trial

Lead sponsor

• Sanofi2 trials

Running trials

• Recruiting

  Brivekimig for the Treatment of Moderate to Severe Hidradenitis Suppurativa

  NCT07170917· Phase 2· Sanofi· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Hidradenitis suppurativa1 recruiting

Closed trials

• Completed

  Pivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate to Severe COPD With Type 2 Inflammation

  NCT04456673· Phase 3· Sanofi· Source